Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study
- DOI
- 10.1186/s41232-024-00332-7
- Published
- 2024-04-25
- Container
- Inflammation and Regeneration
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s41232-024-00332-7,
title = {Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study},
author = {Kenji Suzuki and Yukinori Sameshima and Junji Yokoyama and Shuji Terai and Hiroyuki Yoneyama and Raja Atreya and Markus F. Neurath and Toshifumi Hibi and Hitoshi Asakura},
year = {2024},
journal = {Inflammation and Regeneration},
doi = {10.1186/s41232-024-00332-7},
url = {https://doi.org/10.1186/s41232-024-00332-7}
}RIS
TY - JOUR TI - Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study AU - Kenji Suzuki AU - Yukinori Sameshima AU - Junji Yokoyama AU - Shuji Terai AU - Hiroyuki Yoneyama AU - Raja Atreya AU - Markus F. Neurath AU - Toshifumi Hibi AU - Hitoshi Asakura PY - 2024 JO - Inflammation and Regeneration DO - 10.1186/s41232-024-00332-7 UR - https://doi.org/10.1186/s41232-024-00332-7 ER -
APA
Suzuki, K., Sameshima, Y., Yokoyama, J., Terai, S., Yoneyama, H., Atreya, R., Neurath, M. F., Hibi, T., & Asakura, H. (2024). Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study. Inflammation and Regeneration. https://doi.org/10.1186/s41232-024-00332-7
Source records
- crossref · retrieved 2026-09-26T02:23:30.859Z